i
Cost-effectiveness analysis of BOOSTRIX® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) among Individuals≥ 65 years of age in prevention of Pertussis
-
February 22, 2012
-
-
Series: ACIP meeting Pertussis Vaccines